Ms Rosina Maar

KANDO id: 26435

Bio

Rosina is an internist with strong strategic, business development and operating experience within the biopharmaceutical, outsourcing, and venture capital industries. She joined Pappas Ventures in 2000 after serving in senior management positions at contract research organizations for seven years, including as Vice President, Clinical Operations and Senior Vice President, Strategic Planning for Quintiles Transnational Corporation. She managed the global clinical development program of Actonel, and oversaw the clinical components of projects leading to the approval of more than a dozen product approvals. Rosina was the founder and Managing Director of StratWorks, LLC, a strategic consulting company focused on assisting biopharmaceutical companies with strategy, M&A, product acquisition and product development. Rosina is the Medical Director at Pappas Ventures and currently serves as a board member of Bayhill Therapeutics, Syndax Pharmaceuticals and Lumena Pharmaceuticals. She is a board observer at Afferent Pharmaceuticals and CoLucid Pharmaceuticals. Rosina is also on the board of NCBIO and is an overseer for the Duke University/Wallace Coulter Translational Partners Program. School of Industrial Engineering, Georgia Institute of Technology (BS in Health Systems). Morehouse School of Medicine (MD). Emory University (post-doc training in Internal Medicine). Kenan-Flagler Business School, University of North Carolina at Chapel Hill (Executive MBA).

Career


Pappas Ventures

Partner (past)

Education